Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved ...
Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial ...
Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning. Moderna’s ...
Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...
There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...
BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
Norovirus outbreaks are popping up around the United States, causing concern during a winter when other illnesses also seem especially virulent. "Between August 1, 2024, and January 15 ...
As cases of norovirus continue to rise across the UK this winter, it's important to know if you've been struck down with the contagious illness. Dubbed the "winter vomiting bug", norovirus causes ...
A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...